論文・技術情報追加のお知らせ

①Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.

SGLT2isと有害事象の関連性推定研究

対象DB：FAERS

②Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study.

VEGF阻害剤の硝子体内使用と腎臓有害事象との関連性探索研究

対象DB：FAERS

③Reports of Guillain-Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database.

COVID-19ワクチン接種後におけるギラン・バレー症候群の報告についての分析研究

対象DB：VAERS

④Death and Disability Reported with Cases of Vaccine Anaphylaxis Stratified by Administration Setting: An Analysis of the Vaccine Adverse Event Reporting System from 2017 to 2022.

投与環境別ワクチンアナフィラキシー症例の比較研究

対象DB：VAERS

⑤Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases.

PPIの使用による横紋筋融解症リスク上昇についての解析研究

対象DB：FAERS,MDV

⑥Impact of Concomitant Use of Azoles on Bortezomib-related Adverse Drug Reactions Using JADER.

ボルテゾミブ関連副作用に対するアゾール系薬剤の影響調査研究

対象DB：JADER

⑦Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study.

小児におけるCOVID-19ワクチンの安全性評価研究

対象DB：EudraVigilance